Reports for DOXORUBICIN HYDROCHLORIDE INJECTION

Brand name

DOXORUBICIN HYDROCHLORIDE INJECTION

Company Name
TEVA CANADA LIMITED
Drug Identification Number
02409275
Ingredients
DOXORUBICIN HYDROCHLORIDE
Ingredient Strength
2 MG
ATC Code
L01DB
ATC Descriptor
CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Status
MARKETED
Shortage reports
Brand name Packaging size Status Date Created Date Updated Reports
DOXORUBICIN HYDROCHLORIDE INJECTION 25ml VIAL Resolved 2022-01-20 2022-04-21 153156
DOXORUBICIN HYDROCHLORIDE INJECTION 100ml Resolved 2025-01-30 2025-03-20 249213
DOXORUBICIN HYDROCHLORIDE INJECTION 25ml Resolved 2025-01-30 2025-04-24 249210
DOXORUBICIN HYDROCHLORIDE INJECTION 5ml Actual shortage 2024-06-07 2025-03-27 229963
DOXORUBICIN HYDROCHLORIDE INJECTION 100ML Resolved 2023-06-20 2023-10-19 195806
DOXORUBICIN HYDROCHLORIDE INJECTION 5ML Resolved 2023-06-16 2023-07-05 195219
DOXORUBICIN HYDROCHLORIDE INJECTION 5ml Resolved 2023-01-12 2023-10-06 180891
DOXORUBICIN HYDROCHLORIDE INJECTION 25 Resolved 2022-11-14 2023-01-12 174595
DOXORUBICIN HYDROCHLORIDE INJECTION 100ml Resolved 2022-02-17 2022-03-24 155155
DOXORUBICIN HYDROCHLORIDE INJECTION 100ML Resolved 2018-06-22 2018-10-11 52823

Showing 1 to 10 of 17

Discontinuation reports
Brand name Packaging size Status Date Created Date Updated Reports

Showing 1 to 0 of 0